MindWalk Holdings Corp. has announced a scientific advance in its universal influenza program, identifying a breakthrough functional constraint that remains consistent across both Influenza A and B viruses, including challenging subtypes such as H3N2 subclade K and zoonotic strains H5, H7, and H9. Using its proprietary HYFT® Deep Data technology, the company uncovered a preserved biological requirement that influenza viruses must maintain for infection, moving beyond traditional approaches that focus on genetic sequence changes. MindWalk states that this discovery could improve decision quality and reduce failure in drug discovery by enabling rational vaccine design. The company did not specify whether these research results have already been presented or will be presented at a future event.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MindWalk Holdings Corp. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260109786549) on January 10, 2026, and is solely responsible for the information contained therein.